Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crawford & Company B | CRD-B | Sep 20, 2024 | 11.43 | +5.93 |
Creative Media & Community Trust | CMCT | Sep 20, 2024 | 2.06 | +7.85 |
Creative Medical Technology | CELZ | Sep 20, 2024 | 3.12 | +0.32 |
Creative Realities | CREX | Sep 20, 2024 | 4.40 | -1.12 |
Credicorp | BAP | Sep 20, 2024 | 179.40 | -0.38 |
Credit Acceptance | CACC | Sep 20, 2024 | 453.56 | -2.29 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Sep 20, 2024 | 26.89 | +0.39 |
Credit Suisse Ag | SLVO | Sep 20, 2024 | 79.63 | -1.55 |
Credit Suisse Ag | GLDI | Sep 20, 2024 | 154.62 | -0.97 |
Credit Suisse Asset Management Income Fund | CIK | Sep 20, 2024 | 3.08 | +0.16 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Sep 20, 2024 | 66.87 | -2.93 |
Credit Suisse High Yield Bond Fund | DHY | Sep 20, 2024 | 2.17 | -0.46 |
Credo Technology | CRDO | Sep 20, 2024 | 29.18 | +0.69 |
Crescent Capital BDC | CCAP | Sep 20, 2024 | 18.88 | -0.53 |
Crescent Energy | CRGY | Sep 20, 2024 | 11.44 | -0.09 |
Cresud A ADR | CRESY | Sep 20, 2024 | 8.94 | -3.14 |
Crexendo | CXDO | Sep 20, 2024 | 4.70 | -1.67 |
CRH | CRH | Sep 20, 2024 | 92.89 | +0.17 |
Cricut A | CRCT | Sep 20, 2024 | 6.51 | -0.61 |
Crinetics Pharmaceuticals | CRNX | Sep 20, 2024 | 53.15 | -1.35 |
CRISPR Therapeutics | CRSP | Sep 20, 2024 | 48.18 | -2.65 |
Criteo ADR | CRTO | Sep 20, 2024 | 42.00 | -1.64 |
Critical Metals | CRML | Sep 20, 2024 | 7.00 | -9.21 |
Crocs | CROX | Sep 20, 2024 | 139.05 | +0.82 |
Cronos Group | CRON | Sep 20, 2024 | 2.15 | -3.59 |
Cross Country Healthcare | CCRN | Sep 20, 2024 | 14.53 | -2.87 |
Cross Timbers Royalty Royalty Trust | CRT | Sep 20, 2024 | 9.79 | +5.27 |
CrossAmerica Partners LP Unit | CAPL | Sep 20, 2024 | 21.27 | +1.43 |
CrossFirst Bankshares | CFB | Sep 20, 2024 | 17.40 | -1.42 |
CrowdStrike A | CRWD | Sep 20, 2024 | 299.85 | +8.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.